Axiom Investors LLC DE Boosts Holdings in Exponent, Inc. (NASDAQ:EXPO)

Axiom Investors LLC DE raised its holdings in shares of Exponent, Inc. (NASDAQ:EXPO) by 1.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 118,567 shares of the business services provider’s stock after purchasing an additional 1,810 shares during the period. Axiom Investors LLC DE’s holdings in Exponent were worth $10,564,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Vanguard Group Inc. raised its stake in Exponent by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 5,345,503 shares of the business services provider’s stock valued at $476,284,000 after buying an additional 67,296 shares during the last quarter. State Street Corp boosted its stake in Exponent by 0.7% in the 3rd quarter. State Street Corp now owns 1,840,313 shares of the business services provider’s stock worth $212,151,000 after purchasing an additional 13,644 shares in the last quarter. Geode Capital Management LLC grew its position in Exponent by 4.8% during the 3rd quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider’s stock worth $173,597,000 after purchasing an additional 69,099 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Exponent by 63.6% in the third quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock worth $72,701,000 after buying an additional 245,086 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of Exponent during the fourth quarter worth $55,131,000. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Exponent Stock Up 0.2 %

Shares of NASDAQ:EXPO opened at $82.23 on Monday. The business has a 50-day moving average price of $86.78 and a 200-day moving average price of $95.63. The stock has a market cap of $4.18 billion, a price-to-earnings ratio of 38.79 and a beta of 0.77. Exponent, Inc. has a 52-week low of $77.30 and a 52-week high of $115.75.

Exponent (NASDAQ:EXPO) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same quarter last year, the business earned $0.41 EPS. As a group, equities analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current fiscal year.

Insider Activity at Exponent

In other news, VP Richard Reiss sold 1,736 shares of the stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total transaction of $149,174.48. Following the transaction, the vice president now owns 1,800 shares in the company, valued at $154,674. This trade represents a 49.10 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 2.10% of the stock is owned by company insiders.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.